Product registration and post approval variation

Main guidance

• Guidance on Therapeutic Product Registration in Singapore (Dec 2020)1489 KB (updated 31 Dec 2020)

Appendices

1. Patent Declaration Forms (updated January 2019)431 KB
2. ICH CTD checklists
   • Application checklist for NDA and GDA (ICH CTD)187 KB (updated 31 Dec 2020) 
   • Application checklist for MAV (ICH CTD)81 KB (updated 31 Dec 2020)
3. ACTD checklists
   
   • Application checklist for NDA and GDA (ACTD)187 KB (updated 31 Dec 2020)
   • Application checklist for MAV (ACTD)82 KB (updated 31 Dec 2020)
4. Sample Verification Document for Translator7 KB
5. Target Processing Timelines171 KB
6. Guideline on Submission for Non-Prescription Therapeutic Products165 KB
7. Points to Consider for Singapore Labelling177 KB

• Guidance for Electronic Labelling Aug 2019 (draft version for pilot run) 230 KB

  8. Guideline on the Registration of Human Plasma-derived Therapeutic Products79 KB

 9. Guideline on the Registration of Human Therapeutic Products Containing Materials of Animal Origin219 KB

• Checklist for Registration of Human Therapeutic Products Containing Materials of Animal Origin24 KB

10. Product Interchangeability and Biowaiver Request for Chemical Generic Drug Applications95 KB

11. Guidance on Drug Master File180 KB

• DMF Submission Form Template271 KB

• Sample Letter of Access for DMF298 KB

12. MIV online enquiry form

• Self-guided tool for Post-Approval Variation Selection378 KB

13. Guidance on MIV Applications for Chemical Therapeutic Products980 KB

• Part A: Checklist on Dossier Requirements for MIV 1 Variation for Chemical Therapeutic Products187 KB (Word version79 KB)
• Part B: Checklist on Dossier Requirements for MIV-2 (Notification) Variation for Chemical Therapeutic Products318 KB (Word version85 KB)
• Part C: Checklist on Dossier Requirements for MIV-2 (Do-and-Tell) Variation for Chemical Therapeutic Products213 KB (Word version56 KB)

14. Guidance on MIV Applications for Biological Therapeutic Products689 KB

• Part A: Checklist on Dossier Requirements for MIV-1 Variation for Biological Therapeutic Products142 KB (Word version62 KB)
• Part B: Checklist on Dossier Requirements for MIV-2 (Notification) Variation for Biological Therapeutic Products216 KB (Word version57 KB)
• Part C: Checklist on Dossier Requirements for MIV-2 (Do-and-Tell) Variation for Biological Therapeutic Products200 KB (Word version48 KB)

15. Guidance on Registration of Biosimilar Products254 KB

16. Guideline on Submission Requirements for Risk Management Plan Documents166 KB

• Singapore-Specific Annex (SSA) Template424 KB

17. Guideline on PRISM Submission2144 KB (updated 31 Dec 2020)

18. Confirmation of Quality Dossiers with Reference Agency's Approval357 KB

• Dossier Clarification Supplement169 KB

Retention on Therapeutic Product Register

• Guidance for Retention of Therapeutic Product on the Product Register266 KB

Change of registrant

• Guidance on Change of Registrant for Registered Therapeutic Product178 KB

ASEAN Common Technical Dossier (ACTD)

ASEAN Registration of Pharmaceuticals for Human Use

• Organisation of the Dossier107 KB
• Glossary used for the ACTD and ACTR306 KB
• Part II: Quality198 KB
• Part III: Nonclinical Document869 KB
• Part IV: Clinical Document346 KB
• ACTD Clinical Check List for Product Classification165 KB

ASEAN Common Technical Requirements (ACTR)

• ASEAN Variation Guideline (version 7.2)741 KB
• ASEAN Guideline on Submission of Manufacturing Process Validation Data for Drug Registration (includes all annexes)983 KB
• ASEAN Guideline on Submission of Manufacturing Process Validation Data for Drug Registration149 KB
  • Annex A1 Guidance on Process Validation Scheme for Solid Oral Dosage Products230 KB
  • Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products142 KB
  • Annex A3 Guidance on Process Validation Scheme for Terminally Sterilised Products117 KB
  • Annex B Table of Content of Process Validation Documentation82 KB 
  • Annex C Guidance for Quality By Design as an Alternative Approach to Process Validation308 KB
  • ANNEX D48 KB
• ASEAN Guideline for the Conduct of Bioavailability and Bioequivalence Studies592 KB
• ASEAN Guideline on Stability Study of Drug Product (R1)1161 KB
• ASEAN Guideline for Validation of Analytical Procedures122 KB
• ASEAN Guideline on Process Validation Q&A123 KB
• ASEAN Guideline on Analytical Validation Q&A149 KB

Dealer's licensing and certification

Good Distribution practice (GDP) guides

• GUIDE-13 Good Distribution Practice240 KB  
• GUIDE-22 Guidance Notes on Preparation of a Site Master File for Good Distribution Practice Certification269 KB
• GUIDE-28 Guidance Notes on Duties of Responsible Persons Named in the Importer's Licence and Wholesaler's Licence140 KB

Good Manufacturing Practice (GMP) guides

HSA guides

• Audit and Licensing Of Pharmaceutical Manufacturers (GUIDE-MQA-002)188 KB
• Good Manufacturing Practice For Assemblers Of Medicinal Products (GUIDE-MQA-017)233 KB
• Preparation of a Quality System Dossier (GUIDE-MQA-019)271 KB
• GMP Conformity Assessment of an Overseas Manufacturer (GUIDE-MQA-020)493 KB

PIC/S guides

• Pharmaceutical Inspection Convention/Co-operation Scheme (PIC/S) Guide to Good Manufacturing Practice (GMP) for Medicinal Products
• Explanatory Notes for Pharmaceutical Manufacturers on the Preparation of a Site Master File (PIC/S PE 008-4)
• Recommendation on Sterility Testing (PIC/S PI 012-3)
• Validation Master Plan, Installation and Operational Qualification, Non-sterile Process validation, Cleaning validation (PIC/S PI 006-3)
• Validation of Aseptic Processes (PIC/S PI 007-6)

WHO guides

• WHO Guide on Water Pharmaceutical Use
• WHO guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms

Retail pharmacy licensing

• GUIDE-29 Guidance Notes on Supply of Registered General Sale List (GSL) Therapeutic Products and other Medicinal Products via Automated Vending Machines141 KB
• GUIDE-32 Guidance Notes on Supply of Registered Therapeutic Products through e-pharmacy521 KB

Safety monitoring and product recall

Post-Marketing Vigilance Requirements for Therapeutic Products

• Guidance for Industry_Post-marketing Vigilance Requirements for Therapeutic Products659 KB
• FAQ on Risk Management Plan Industry Consultation275 KB

Reporting of Therapeutic Product Defects and Recall of Therapeutic Products

• Guidance for Industry- Reporting of Therapeutic Product Defects and Recall of Therapeutic Products766 KB
• FAQ on reporting of therapeutic product defects and recall of therapeutic products232 KB
• Online Product Defect Reporting Form
• Online Product Recall Completion Form

Advertisements and promotions

• Explanatory Guidance to the Health Products (Advertisement of Therapeutic Products) Regulations 2016279 KB
  • FAQ on Advertisement Controls for Therapeutic Products80 KB

Special Access Routes (SAR)

• Guidance for Application to Import a Therapeutic Product on Consignment Basis241 KB (for non-authorised importers)
•  Guidance for Import and Supply of an Unregistered Therapeutic Product for Patient Use220 KB 
  • Signed Request form for Named-Patient Application Type158 KB
  • Signed Request Form for Buffer Stock Application Type120 KB
• Special Consignment by a Product Registrant 
  • Application form for Special Consignment by a Product Registrant116 KB

Clinical trials of therapeutic products

Refer to our clinical trials section for the guidance documents.